Navigation Links
Neurodegenerative diseases: Glitch in garbage removal enhances risk
Date:7/3/2014

An international team of researchers identified a pathogenic mechanism that is common to several neurodegenerative diseases. The findings suggest that it may be possible to slow the progression of dementia even after the onset of symptoms.

The relentless increase in the incidence of dementia in aging societies poses an enormous challenge to health-care systems. An international team of researchers led by Professor Christian Haass and Gernot Kleinberger at the LMU's Adolf-Butenandt-Institute and the German Center for Neurodegenerative Diseases (DZNE), has now elucidated the mode of action of a genetic defect that contributes to the development of several different dementia syndromes.

Neurodegenerative disorders such as Alzheimer's and Parkinson's diseases or frontotemporal dementia display a number of common features. They are all characterized by the appearance in the brains of affected patients of abnormally high levels of insoluble protein deposits, which are associated with massive loss of nerve cells. In order to minimize further damage to nerve cells in the vicinity of such deposits, dead cells and the proteinaceous aggregates released from them must be efficiently degraded and disposed of. This task is performed by specialized phagocytic cells the so-called microglia which act as "sanitary inspectors" in the brain to ensure the prompt removal of debris that presents a danger to the health of nearby cells. Microglia are found only in the central nervous system, but functionally they represent a division of the body's innate immune system.

As Haass and his colleagues now report in the latest issue of the journal Science Translational Medicine, specific mutations in the gene for a protein called TREM2, which regulates the uptake of waste products by microglia, lead to its absence from the cell surface. TREM2 is normally inserted into the plasma membrane of microglial cells such that part of it extends through the membrane as an extracellular domain. This exposed portion of TREM2 is responsible for the recognition of waste products left behind by dead cells. "We believe that the genetic defect disrupts the folding of the protein chain soon during its synthesis in the cell, so that it is degraded before it can reach the surface of the microglia," says Kleinberger. As a result, the amount of debris that the microglia can cope with is significantly reduced. Consequently, the toxic protein deposits, as well as whole dead cells, cannot be efficiently removed and continue to accumulate in the brain. This is expected to trigger inflammatory reactions that may promote further nerve-cell loss.

The new study thus pinpoints a mechanism that influences the course of several different brain diseases. "In addition, our findings may perhaps point to ways of slowing the rate of progression of these illnesses even after the manifestation of overt signs of dementia, which has not been possible so far," says Haass. "That this may indeed be feasible is suggested by the initial results of an experiment in which we were able to stimulate the phagocytic activity of microglia by pharmacological means."


'/>"/>

Contact: Luise Dirscherl
presse@lmu.de
0049-892-180-3423
Ludwig-Maximilians-Universitt Mnchen
Source:Eurekalert

Related biology news :

1. New insight into protein misfolding in neurodegenerative disorders
2. Study led by NUS scientists provides new insights into cause of human neurodegenerative disease
3. Shining light on neurodegenerative pathway
4. Oxidative stress, mitochondrial damage and neurodegenerative diseases
5. Transatlantic partnership to tackle neurodegenerative disease
6. Grant to fund development of drug candidates for rheumatoid arthritis, neurodegenerative disorders
7. Removing protein garbage in nerve cells may help control 2 neurodegenerative diseases
8. Learning faster with neurodegenerative disease
9. Cell research opens new avenues in combating neurodegenerative diseases
10. Renaissance in new drugs for rare diseases: Report in worlds largest scientific socity magazine
11. Symposium: Protein-Folding Diseases: Models & Mechanisms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2019)... ... 31, 2019 , ... The University of Vermont Health Network ... $6M Series B Financing Round. , “With the commitment from the UVM ... financial and business resources to bear as we advance our biopharmaceutical products to ...
(Date:5/31/2019)... (PRWEB) , ... May 30, 2019 , ... ... genetics testing company, and Mayo Clinic, have documented significant differences in the prevalence ... racial and ethnic populations compared to non-Hispanic White women. Results will be presented ...
(Date:5/31/2019)... ... May 30, 2019 , ... Enso Discoveries Chief Executive Officer, ... Military Appreciation Month, as a way to express his gratitude and respect for those ... he founded — Enso Discoveries — presented a check for $1,000 to ...
Breaking Biology News(10 mins):
(Date:6/12/2019)... ... June 12, 2019 , ... Leak Detection Associates (LDA), ... Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries, is excited to announce that ... grant exclusive rights for Zillion to represent LDA in all of China. ...
(Date:6/11/2019)... Calif. (PRWEB) , ... June 10, 2019 , ... ... today announced IOPP will add 80 of its scientific journals to DeepDyve’s rental ... physics-related content to DeepDyve’s continually expanding library of more than 20 million articles, ...
(Date:6/11/2019)... N.C. (PRWEB) , ... June 11, 2019 , ... ... extracellular vesicles derived from human mesenchymal stem cells (MSC-EV) are able to incorporate ... cloning ability. In a test on mice, MSC-EVs also increased the cells’ ability ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... providing proprietary interest to our methodology, processes, and diagnostic techniques. The patent ... extends Somnology’s IP rights including our proprietary sleep scoring methodology. The approval ...
Breaking Biology Technology: